Overview
MMSI market data
Price History
MMSI price chart
Valuation & Profitability
- P/E (TTM)
- 37.68 Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- $2.13 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.52 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- 9.2% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $59.74 – $94.75 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $5.5B · P/B 3.30 · P/S 3.47.
Company News
Brinker International To Rally Around 22%? Here Are 10 Top Analyst Forecasts For ThursdayBenzinga · Aug 13, 2026, 11:41 AM
B of A Securities Maintains Neutral on Merit Medical Systems, Raises Price Target to $97Benzinga · Aug 13, 2026, 9:16 AM
BTIG Reiterates Buy on Merit Medical Systems, Maintains $105 Price TargetBenzinga · Aug 11, 2026, 11:22 AM
Canaccord Genuity Maintains Buy on Merit Medical Systems, Raises Price Target to $94Benzinga · Aug 3, 2026, 9:23 PM
JP Morgan Maintains Overweight on Merit Medical Systems, Raises Price Target to $95Benzinga · Jul 31, 2026, 5:50 PM
Piper Sandler Maintains Overweight on Merit Medical Systems, Raises Price Target to $106Benzinga · Jul 31, 2026, 2:50 PM
Wells Fargo Maintains Equal-Weight on Merit Medical Systems, Raises Price Target to $83Benzinga · Jul 31, 2026, 2:38 PM
Merit Medical Systems shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance. Also, Needham and BTIG raised their respective price targets on the stock.Benzinga · Jul 31, 2026, 1:17 PM
These Analysts Increase Their Forecasts On Merit Medical Systems After Strong Q2 ResultsBenzinga · Jul 31, 2026, 10:42 AM
Needham Maintains Buy on Merit Medical Systems, Raises Price Target to $101Benzinga · Jul 31, 2026, 9:55 AM